DE3578839D1 - Verfahren zur reinigung des japanischen enzephalitisvirus. - Google Patents

Verfahren zur reinigung des japanischen enzephalitisvirus.

Info

Publication number
DE3578839D1
DE3578839D1 DE8585110011T DE3578839T DE3578839D1 DE 3578839 D1 DE3578839 D1 DE 3578839D1 DE 8585110011 T DE8585110011 T DE 8585110011T DE 3578839 T DE3578839 T DE 3578839T DE 3578839 D1 DE3578839 D1 DE 3578839D1
Authority
DE
Germany
Prior art keywords
japanese encephalitis
encephalitis virus
cleaning
chromatography
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585110011T
Other languages
German (de)
English (en)
Inventor
Kuniaki Sakamoto
Isao Gotoh
Tetsuo Kawahara
Mitsuo Sakoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of DE3578839D1 publication Critical patent/DE3578839D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8585110011T 1984-08-09 1985-08-08 Verfahren zur reinigung des japanischen enzephalitisvirus. Expired - Lifetime DE3578839D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59167323A JPS6147185A (ja) 1984-08-09 1984-08-09 日本脳炎ウイルスの精製方法

Publications (1)

Publication Number Publication Date
DE3578839D1 true DE3578839D1 (de) 1990-08-30

Family

ID=15847614

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585110011T Expired - Lifetime DE3578839D1 (de) 1984-08-09 1985-08-08 Verfahren zur reinigung des japanischen enzephalitisvirus.

Country Status (7)

Country Link
US (1) US4725546A (https=)
EP (1) EP0171765B1 (https=)
JP (1) JPS6147185A (https=)
KR (1) KR920009731B1 (https=)
AT (1) ATE54938T1 (https=)
CA (1) CA1251400A (https=)
DE (1) DE3578839D1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248075B (it) * 1991-06-18 1995-01-05 Sclavo Spa Processo per la purificazione del virus dell'epatite a (hav), virus cosi` purificato e composizioni vaccinali che lo contengono.
US5447859A (en) * 1993-07-16 1995-09-05 Viagene Method for the purification or removal of retroviruses using sulfated cellulose
DE69515028T2 (de) * 1994-03-22 2000-06-29 The Immune Response Corp., Carlsbad Die hocheffiziente herstellung und isolierung von viruspartikeln
CN1063970C (zh) * 1994-12-06 2001-04-04 卫生部北京生物制品研究所 用鳞翅目粘虫卵巢细胞制备流行性乙脑疫苗的方法及疫苗
FR2737412B1 (fr) * 1995-08-01 1997-10-24 Pasteur Merieux Serums Vacc Procede de production d'un vaccin contre le virus de l'encephalite japonaise et vaccin obtenu par ce procede
EP0841942B2 (fr) * 1995-08-01 2007-12-12 Sanofi Pasteur Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu
US6207439B1 (en) * 1997-03-25 2001-03-27 Center For Disease Control Purification of Japanese encephalitis virus
US6841374B1 (en) 1998-10-05 2005-01-11 Research Foundation For Microbial Diseases Of Osaka University Enhanced immunogen for inactivated vaccine for infection with Japanese encephalitis viruses and process for producing the same
WO2001076624A1 (en) * 2000-04-07 2001-10-18 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Inactivated japanese b encephalitis vaccine and process for producing the same
JP2002142770A (ja) 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
PL354822A1 (en) * 2002-06-30 2004-01-12 Instytut Immunologii i Terapii Doświadczalnej PANwe Wrocławiu Method of receiving purified bacteriophage preparations and new applications of polysaccharide or its esterificated derivative
JP2007523621A (ja) * 2003-06-18 2007-08-23 オニックス ファーマシューティカルズ，インコーポレイティド ウイルスを精製するための方法
WO2005042737A1 (ja) 2003-11-04 2005-05-12 Dnavec Research Inc. 遺伝子導入された樹状細胞の製造方法
EP1724338A1 (en) * 2005-05-19 2006-11-22 Crucell Holland B.V. Methods for the production of a whole-inactivated West Nile Virus vaccine
WO2006122964A1 (en) * 2005-05-19 2006-11-23 Crucell Holland B.V. Methods for the production of a whole-inactivated west nile virus vaccine
WO2006134917A1 (ja) 2005-06-14 2006-12-21 Dnavec Corporation 抗体の作製方法
CA2636600A1 (en) 2006-01-17 2007-07-26 Dnavec Corporation Novel protein expression system
KR20090052857A (ko) 2006-07-13 2009-05-26 디나벡크 가부시키가이샤 비복제형 파라믹소바이러스과 바이러스 벡터
US20100203027A1 (en) 2007-04-27 2010-08-12 Kyushu Univeristy National University Viral vector for gene therapy
JP5716297B2 (ja) 2009-06-25 2015-05-13 Jnc株式会社 クロマトグラフィー用充填剤、その製造方法、およびそれを用いたウイルス用ワクチンの製造方法
US9644187B2 (en) 2010-04-14 2017-05-09 Emd Millipore Corporation Methods of producing high titer, high purity virus stocks and methods of use thereof
DE102013017014B4 (de) 2013-10-14 2017-03-30 Sartorius Stedim Biotech Gmbh Sulfatierte Cellulosehydrat-Membran, Verfahren zur ihrer Herstellung und Verwendung der Membran als Adsorptionsmembran für die Virenaufreinigung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131092C (https=) *
US3105012A (en) * 1961-10-19 1963-09-24 Parke Davis & Co Antigen products and means for producing the same
SE356735B (https=) * 1970-12-02 1973-06-04 Svenska Cellulosa Ab
JPS565204B2 (https=) * 1972-06-16 1981-02-04
US3842062A (en) * 1972-09-27 1974-10-15 Du Pont Water-soluble complexes of protein and anionic polyelectrolytes such as sodium carboxymethyl cellulose
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4160018A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Stabilized cancer associated polypeptide antigen and preparation thereof
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
JPS53133627A (en) * 1977-04-25 1978-11-21 Nippon Seibutsu Kagaku Kenkiyu High purity deactivated vaccine for japanese encephalitis
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
JPS5879929A (ja) * 1981-11-05 1983-05-13 Biseibutsu Kagaku Kenkyusho:Kk 日本脳炎・豚パルポ混合ワクチン
US4434093A (en) * 1982-07-26 1984-02-28 Ortho Diagnostic Systems Inc. Methods for preparation of HBs Ag free gamma globulins
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen

Also Published As

Publication number Publication date
KR920009731B1 (ko) 1992-10-22
ATE54938T1 (de) 1990-08-15
EP0171765B1 (en) 1990-07-25
JPS6147185A (ja) 1986-03-07
US4725546A (en) 1988-02-16
CA1251400A (en) 1989-03-21
EP0171765A3 (en) 1988-01-13
JPS6233879B2 (https=) 1987-07-23
EP0171765A2 (en) 1986-02-19
KR870001834A (ko) 1987-03-28

Similar Documents

Publication Publication Date Title
DE3578613D1 (de) Verfahren zur reinigung des influenzavirus.
DE3578839D1 (de) Verfahren zur reinigung des japanischen enzephalitisvirus.
ATE50594T1 (de) Verfahren zur reinigung des tollwutvirus.
ATE60996T1 (de) Verfahren zur reinigung von faktor viii-c.
ATE45728T1 (de) Verfahren zur herstellung bestimmter enantiomerenpaare von permethrinsaeure-alpha-cyano-3-phenoxy-4-fluor-b nzyl-ester.
IT1110267B (it) Processo di purificazione di soluzioni di policaronato
BR7908473A (pt) Processo de depuracao de gas acido
IT7829235A0 (it) Processo per isolare e purificare acido acrilico.
ATE8142T1 (de) Verfahren zur herstellung von isosorbid-5-nitrat.
DE3768936D1 (de) Verfahren zur ozon-behandlung von cellulosebrei.
BR8901038A (pt) Processo para isolamento ou purificacao de acidos c14-c24-graxos saturados,preponderantemente metil-ramificados
MX7055E (es) Procedimiento enzimatico mejorado de clarificacion de soluciones acuosas de gomas xantanos para mejorar su filtrabilidad
FI882867A0 (fi) Menetelmä metallipitoisten liuosten puhdistamiseksi
IT8122389A0 (it) Processo per purificare una soluzione acquosa di acrilamide.
IT1074825B (it) Procedimento per la purificazione di acidi alchilsolfonici
ATE20071T1 (de) Verfahren zur reinigung von sekretin.
BR8305451A (pt) Processo de preparacao de derivados de acidos benzoxazolil-e benzotiazolil-oxi-fenoxi-propionicos
ES526195A0 (es) Procedimiento de purificacion de soluciones acuosas uraniferas que contienen impurezas
IT1156314B (it) Procedimento di purificazione di derivati di acidi fenossibenzoici
IT1188938B (it) Procedimento per la puricazione di acido ursodesossicolico
BR7803244A (pt) Processo de purificacao e de desfluoracao de acido fosforico impuro
BR8604269A (pt) Processo de purificacao de licores causticos
IT1208519B (it) Procedimento di purificazione di un enzima.
IT7826932A0 (it) Processo di depurazione biologica di acque usate.
FR2602982B1 (fr) Procede de traitement des residus de reaction obtenue lors de la preparation du fluorure de cyanuryle, sulfolane recupere par ce procede, et reutilisation de ce sulfolane

Legal Events

Date Code Title Description
8364 No opposition during term of opposition